Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo

Journal of Dermatological Science

Volumn 83, Issue 2, 2016, Pages 106-115

  Ehling, Sarah ^a   Roßbach, Kristine ^b   Dunston, Stanley M ^a   Stark, Holger ^c   Bäumer, Wolfgang ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Allergic contact dermatitis; CCL17 TARC; Dermal dendritic cells; Histamine H4 receptor; Natural killer cells

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; CYTOKINE; DNA; HISTAMINE; HISTAMINE H4 RECEPTOR; OVALBUMIN; 1-((5-CHLORO-1H-INDOL-2-YL)CARBONYL)-4-METHYLPIPERAZINE; CCL17 PROTEIN, MOUSE; G PROTEIN COUPLED RECEPTOR; HISTAMINE RECEPTOR; HRH4 PROTEIN, MOUSE; INDOLE DERIVATIVE; N4-(2,6-DICHLOROBENZYL)-6-(4-METHYLPIPERAZIN-1-YL)PYRIMIDINE-2,4-DIAMINE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLUENE DIISOCYANATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATOPIC DERMATITIS; CELL INTERACTION; CELL MIGRATION; CHEMOTAXIS; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; DNA TRANSCRIPTION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SKIN ALLERGY; WILD TYPE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SKIN;

ANIMALS; CHEMOKINE CCL17; CHEMOTAXIS; COCULTURE TECHNIQUES; DENDRITIC CELLS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; FEMALE; HISTAMINE; HUMANS; INDOLES; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; PIPERAZINES; PYRIMIDINES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; SKIN; TOLUENE 2,4-DIISOCYANATE;

EID: 84964803648     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2016.04.011     Document Type: Article

References (50)

1. [1] Pawankar, R., Holgate, S.T., Canonica, G.W., Lockey, R.F., Blaiss, M.S., WAO White Book on Allergy: Update 2013. 2013, World Allergy Organization (WAO).
2. [2] Szepietowski, J.C., McKenzie, R.C., Keohane, S.G., Aldridge, R.D., Hunter, J.A., Atopic and non-atopic individuals react to nickel challenge in a similar way. A study of the cytokine profile in nickel-induced contact dermatitis. Br. J. Dermatol. 137 (1997), 195–200.
3. [3] Eyerich, K., Novak, N., Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 68 (2013), 974–982.
4. [4] Wollenberg, A., Kraft, S., Hanau, D., Bieber, T., Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J. Invest. Dermatol. 106 (1996), 446–453.
5. [5] Perros, F., Hoogsteden, H.C., Coyle, A.J., Lambrecht, B.N., Hammad, H., Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Allergy 64 (2009), 995–1002.
6. [6] von Bubnoff, D., Andres, E., Hentges, F., Bieber, T., Michel, T., Zimmer, J., Natural killer cells in atopic and autoimmune diseases of the skin. J. Allergy Clin. Immunol. 125 (2010), 60–68.
7. [7] Deniz, G., Akdis, M., NK cell subsets and their role in allergy. Exp. Opin. Biol. Therapy 11 (2011), 833–841.
8. [8] Martin, S.F., Immunological mechanisms in allergic contact dermatitis. Curr. Opin. Allergy Clin. Immunol. 15 (2015), 124–130.
9. [9] Mathias, C.B., Guernsey, L.A., Zammit, D., Brammer, C., Wu, C.A., Thrall, R.S., Aguila, H.L., Pro-inflammatory role of natural killer cells in the development of allergic airway disease. Clin. Exp. Allergy 44 (2014), 589–601.
10. [10] O'Leary, J.G., Goodarzi, M., Drayton, D.L., von Andrian, U.H., T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7 (2006), 507–516.
11. [11] Rouzaire, P., Luci, C., Blasco, E., Bienvenu, J., Walzer, T., Nicolas, J.F., Hennino, A., Natural killer cells and T cells induce different types of skin reactions during recall responses to haptens. Eur. J. Immunol. 42 (2012), 80–88.
12. [12] Asherson, G.L., Ptak, W., Contact and delayed hypersensitivity in the mouse. 3. Depression of contact sensitivity by pre-treatment with antigen and the restoration of immune competence in tolerant mice by normal lymphoid and bone marrow cells. Immunology 18 (1970), 99–106.
13. [13] Mahapatra, S., Albrecht, M., Behrens, B., Jirmo, A., Behrens, G., Hartwig, C., Neumann, D., Raap, U., Bahre, H., Herrick, C., Dittrich, A.M., Delineating the role of histamine-1- and −4-receptors in a mouse model of Th2-dependent antigen-specific skin inflammation. PLoS One, 9, 2014, pe87296.
14. [14] Bäumer, W., Seegers, U., Braun, M., Tschernig, T., Kietzmann, M., TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines. Br. J. Dermatol. 151 (2004), 823–830.
15. [15] Dunford, P.J., O'Donnell, N., Riley, J.P., Williams, K.N., Karlsson, L., Thurmond, R.L., The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J. Immunol. (Baltimore Md.: 1950) 176 (2006), 7062–7070.
16. [16] Amaral, M.M., Davio, C., Ceballos, A., Salamone, G., Canones, C., Geffner, J., Vermeulen, M., Histamine improves antigen uptake and cross-presentation by dendritic cells. J. Immunol. (Baltimore Md.: 1950) 179 (2007), 3425–3433.
17. [17] Bangert, C., Friedl, J., Stary, G., Stingl, G., Kopp, T., Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease?. J. Invest. Dermatol. 121 (2003), 1409–1418.
18. [18] Buentke, E., Heffler, L.C., Wilson, J.L., Wallin, R.P., Lofman, C., Chambers, B.J., Ljunggren, H.G., Scheynius, A., Natural killer and dendritic cell contact in lesional atopic dermatitis skin–Malassezia-influenced cell interaction. J. Invest. Dermatol. 119 (2002), 850–857.
19. [19] Peng, H., Jiang, X., Chen, Y., Sojka, D.K., Wei, H., Gao, X., Sun, R., Yokoyama, W.M., Tian, Z., Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Invest. 123 (2013), 1444–1456.
20. [20] Vivier, E., Raulet, D.H., Moretta, A., Caligiuri, M.A., Zitvogel, L., Lanier, L.L., Yokoyama, W.M., Ugolini, S., Innate or adaptive immunity? The example of natural killer cells. Science (New York, N.Y.) 331 (2011), 44–49.
21. [21] Majewska-Szczepanik, M., Paust, S., von Andrian, U.H., Askenase, P.W., Szczepanik, M., Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-alpha, interferon-gamma and interleukin-12. Immunology 140 (2013), 98–110.
22. [22] Tomasello, E., Yessaad, N., Gregoire, E., Hudspeth, K., Luci, C., Mavilio, D., Hardwigsen, J., Vivier, E., Mapping of NKp46(+) cells in healthy human lymphoid and non-lymphoid tissues. Front. Immunol., 3, 2012, p344.
23. [23] Thurmond, R.L., Chen, B., Dunford, P.J., Greenspan, A.J., Karlsson, L., La, D., Ward, P., Xu, X.L., Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979. J. Pharmacol. Exp. Ther. 349 (2014), 176–184.
24. [24] Hofstra, C.L., Desai, P.J., Thurmond, R.L., Fung-Leung, W.P., Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305 (2003), 1212–1221.
25. [25] Ling, P., Ngo, K., Nguyen, S., Thurmond, R.L., Edwards, J.P., Karlsson, L., Fung-Leung, W.P., Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. 142 (2004), 161–171.
26. [26] Gutzmer, R., Diestel, C., Mommert, S., Kother, B., Stark, H., Wittmann, M., Werfel, T., Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J. Immunol. (Baltimore Md.: 1950) 174 (2005), 5224–5232.
27. [27] Czerner, C.P., Klos, A., Seifert, R., Neumann, D., Histamine induces chemotaxis and phagocytosis in murine bone marrow-derived macrophages and RAW 264.7 macrophage-like cells via histamine H4-receptor. Inflammation Res. 63 (2014), 239–247 (Official journal of the European Histamine Research Society …[et al.]).
28. [28] Mommert, S., Dittrich-Breiholz, O., Stark, H., Gutzmer, R., Werfel, T., The histamine h4 receptor regulates chemokine production in human natural killer cells. Intl. Arch. Allergy Immunol. 166 (2015), 225–230.
29. [29] Damaj, B.B., Becerra, C.B., Esber, H.J., Wen, Y., Maghazachi, A.A., Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. J. Immunol. (Baltimore Md.: 1950) 179 (2007), 7907–7915.
30. [30] Cowden, J.M., Yu, F., Banie, H., Farahani, M., Ling, P., Nguyen, S., Riley, J.P., Zhang, M., Zhu, J., Dunford, P.J., Thurmond, R.L., The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann. Rheum. Dis. 73 (2014), 600–608.
31. [31] Schaper, K., Kietzmann, M., Bäumer, W., Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells. Mol. Immunol. 59 (2014), 10–18.
32. [32] Luci, C., Reynders, A., Ivanov, I.I., Cognet, C., Chiche, L., Chasson, L., Hardwigsen, J., Anguiano, E., Banchereau, J., Chaussabel, D., Dalod, M., Littman, D.R., Vivier, E., Tomasello, E., Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10 (2009), 75–82.
33. [33] Walzer, T., Blery, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S.H., Jaeger, S., Andre, P., Gauthier, L., Daniel, L., Chemin, K., Morel, Y., Dalod, M., Imbert, J., Pierres, M., Moretta, A., Romagne, F., Vivier, E., Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Nat. Acad. Sci. U. S. A. 104 (2007), 3384–3389.
34. [34] Glatzer, F., Gschwandtner, M., Ehling, S., Rossbach, K., Janik, K., Klos, A., Bäumer, W., Kietzmann, M., Werfel, T., Gutzmer, R., Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor. J. Allergy Clin. Immunol. 132 (2013), 1358–1367.
35. [35] Bäumer, W., Wendorff, S., Gutzmer, R., Werfel, T., Dijkstra, D., Chazot, P., Stark, H., Kietzmann, M., Histamine H4 receptors modulate dendritic cell migration through skin–immunomodulatory role of histamine. Allergy 63 (2008), 1387–1394.
36. [36] Bäumer, W., Wlaz, P., Jennings, G., Rundfeldt, C., The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models. Eur. J. Pharmacol. 628 (2010), 226–232.
37. [37] Schaper, K., Dickhaut, J., Japtok, L., Kietzmann, M., Mischke, R., Kleuser, B., Bäumer, W., Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J. Dermatol. Sci. 71 (2013), 29–36.
38. [38] Spergel, J.M., Mizoguchi, E., Brewer, J.P., Martin, T.R., Bhan, A.K., Geha, R.S., Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101 (1998), 1614–1622.
39. [39] Luci, C., Gaudy-Marqueste, C., Rouzaire, P., Audonnet, S., Cognet, C., Hennino, A., Nicolas, J.F., Grob, J.J., Tomasello, E., Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis. Br. J. Dermatol. 166 (2012), 789–796.
40. [40] Sander, K., Kottke, T., Tanrikulu, Y., Proschak, E., Weizel, L., Schneider, E.H., Seifert, R., Schneider, G., Stark, H., 2,4-Diaminopyrimidines as histamine H4 receptor ligands–Scaffold optimization and pharmacological characterization. Bioorg. Med. Chem. 17 (2009), 7186–7196.
41. [41] Cowden, J.M., Zhang, M., Dunford, P.J., Thurmond, R.L., The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J. Invest. Dermatol. 130 (2010), 1023–1033.
42. [43] Roda-Navarro, P., Vales-Gomez, M., Chisholm, S.E., Reyburn, H.T., Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 11258–11263.
43. [44] Wehner, R., Dietze, K., Bachmann, M., Schmitz, M., The bidirectional crosstalk between human dendritic cells and natural killer cells. J. Innate Immun. 3 (2011), 258–263.
44. [45] Antonelli, A., Ferrari, S.M., Giuggioli, D., Ferrannini, E., Ferri, C., Fallahi, P., Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun. Rev. 13 (2014), 272–280.
45. [46] Chai, O.H., Park, S.G., Sohn, J.S., Hwang, S.S., Li, G.Z., Han, E.-, Kim, H.T., Lee, M.S., Lee, H.-, Lee, Y.C., Song, C.H., A murine model of toluene diisocyanate-induced contact hypersensitivity. Immun. Network [Online] 2 (2002), 158–165.
46. [47] Packard, K.A., Khan, M.M., Effects of histamine on Th1/Th2 cytokine balance. Intl. Immunopharmacol. 3 (2003), 909–920.
47. [48] Hashimoto, S., Suzuki, T., Dong, H.Y., Nagai, S., Yamazaki, N., Matsushima, K., Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 94 (1999), 845–852.
48. [49] Mori, T., Kabashima, K., Yoshiki, R., Sugita, K., Shiraishi, N., Onoue, A., Kuroda, E., Kobayashi, M., Yamashita, U., Tokura, Y., Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines. J. Invest. Dermatol. 128 (2008), 1719–1727.
49. [50] Vestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K., Larsen, C.G., A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA + CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115 (2000), 640–646.
50. [51] Lieberam, I., Forster, I., The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells. Eur. J. Immunol. 29 (1999), 2684–2694.